Clinical variables in this study included tumour anatomical site, tumour thickness, tumour subtype, solar elastosis score, pigmentation scores and BRAF/NRAS mutation status (known oncogenic drivers in melanoma). This evidence concerns the gene NRAS and neoplasm.